BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26

• Press Releases

  4DMT Announces New Employment Inducement Grants - May 15, 2026

  May 17, 2026

   · 

  2 min read
• Press Releases

  ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancer

  May 17, 2026

   · 

  19 min read
• Press Releases

  Enhertu® Approved in the U.S. for Two New Indications for Patients with HER2 Positive Early Breast Cancer

  May 17, 2026

   · 

  19 min read
• Press Releases

  ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory for the Tokyo Strain of BCG to Enhance BCG Supply in the United States

  May 17, 2026

   · 

  11 min read
• Press Releases

  New Real-World Case Series Examines Re-Induction with ADSTILADRIN® (nadofaragene firadenovec-vncg) in Clinical Practice

  May 17, 2026

   · 

  9 min read
• Press Releases

  United Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Presented at ATS 2026

  May 17, 2026

   · 

  10 min read
• Press Releases

  Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfaction

  May 17, 2026

   · 

  8 min read
• Press Releases

  Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

  May 17, 2026

   · 

  7 min read
• Press Releases

  New PSMAddition data show 58% lower risk of PSA progression with Pluvicto® in metastatic hormone-sensitive prostate cancer

  May 17, 2026

   · 

  8 min read
• Press Releases

  Nabsys Announces New OhmX Platform Installations Under Hitachi High-Tech America’s RAMP UP Program with Leading Cytogeneticist to Advance Applications in Hematologic Malignancies

  May 17, 2026

   · 

  7 min read